Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06360900 · ClinicalTrials.gov registry record · NA
Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia
A NA study of Functional Dyspepsia, sponsored by Spaulding Rehabilitation Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06360900: Recruiting NA study of Functional Dyspepsia, sponsored by Spaulding Rehabilitation Hospital.
NCT06360900 is a NA study of Functional Dyspepsia that is actively recruiting participants, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 80 participants, above the 64-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (25% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06360900, a NA study of Functional Dyspepsia, is actively recruiting participants, sponsored by Spaulding Rehabilitation Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims at evaluating physiological and patient-reported outcomes for a dual intervention approach including a stimulation device and support therapy in patients with functional dyspepsia.
Primary Outcome
GI-related anxiety; score ranging from score ranging from 0 to 75, with higher scores indicating worse outcomes
Conditions Studied
Interventions
- BEHAVIORAL Health Education
- DEVICE Sensory device
- BEHAVIORAL Skills Building
- DEVICE Subsensory device
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-10-29 |
| Est. Completion | 2029-03 |
| Phase | NA |
What NCT06360900 shows while recruiting
NCT06360900 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 64-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (25% higher).
The record links to 1 condition, with Functional Dyspepsia appearing as the primary indexed condition, and to 4 interventions - of which Health Education is the first listed.
NCT06360900 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06360900 about?
NCT06360900 is a clinical study titled "Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia". The study aims at evaluating physiological and patient-reported outcomes for a dual intervention approach including a stimulation device and support therapy in patients with functional dyspepsia.
What is the current status of trial NCT06360900?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-10-29. Estimated completion is 2029-03.
What conditions does trial NCT06360900 study?
This clinical trial studies the following conditions: Functional Dyspepsia.
What interventions are being tested in trial NCT06360900?
The interventions under investigation include: Health Education (BEHAVIORAL), Sensory device (DEVICE), Skills Building (BEHAVIORAL), Subsensory device (DEVICE).
Who is sponsoring clinical trial NCT06360900?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06360900 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Functional Dyspepsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06360900's enrollment target sits among peer trials
80 3rd of 9 higher than 7 of 9 other Functional Dyspepsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Functional Dyspepsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
Autonomic Reactivity and Personalized Neurostimulation
RECRUITING · NA
-
Functional Dyspepsia Treatment Using Virtual Reality
RECRUITING · NA
-
Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)
RECRUITING · NA
-
Cerebral Cortical Influences on Autonomic Function
ACTIVE NOT RECRUITING · NA
-
Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI